Duearity Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Duearity
Access all reports
Duearity AB is a Swedish medical technology company specializing in innovative solutions for tinnitus treatment. The company's primary product, Tinearity G1, is a medical device designed to alleviate tinnitus symptoms through a non-invasive method that uses white noise delivered via the skull bone, bypassing the ear canal. This approach is based on Tinnitus Retraining Therapy, which has been used clinically for several decades. The company is headquartered in Malmö, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
Texas Instruments: From Calculators to Master Capital Allocators
Texas Instruments has undergone many transformations from its origins in oil exploration to become one of the world's largest semiconductor producers.
11 Oct 2024
The Art of Portfolio Management: Lessons from Tom O'Hara
Tom O'Hara shares insights on stock picking, navigating market distractions, and the importance of one-on-one meetings with management teams.
4 Oct 2024
The Samsung Co-CEOs: Jong-Hee Han & Young-Hyun Jun
Samsung Electronics' dual-CEO structure, led by Jong-Hee Han and Young-Hyun Jun, is designed to navigate the complexities of its diverse business.
3 Oct 2024
Ticker symbol
DEAR
Country
🇸🇪 Sweden